Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The growing population across the globe had led the demand for fish vaccine. Fish vaccine plays an important role for safety and health of fish. Majority increasing fish farming is projected to increase the demand for fish vaccine market. Besides, fish vaccine maintain the immune system and protect from infectious disease. Further these vaccine helps to improve survival and reduces the cost of production for fish. The market is expected to have significant growth during the forecast period.
The market is driven by increasing development and launch of new aquaculture vaccines for varieties of fishes in market which provide an opportunity to key players to innovate new products. Besides increasing aquaculture production across the globe due to increasing population and consumption of fishes and fish farming is fueling the demand .Also, rising adoption of aquaculture vaccines over antibiotics is boosting growth of the market. Surging prevalence of bacterial and viral infections for fish is also fueling the growth of the market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the fish vaccine market. In addition, complete analysis of changes on the fish vaccine market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The fish vaccine market is segmented based on vaccine type, application, species, route of administration, distribution channel and geography.
The fish vaccine is accessible in market according to different types including inactivated vaccine, attenuated vaccine, toxoid vaccine, subunit vaccine and conjugate vaccine. Inactivated vaccine is majorly used in fish to protect against infectious disease and viral, bacterial infection. Also, it also stimulate proper health and protection from diseases. Further these vaccine are easily accessible in market which increases the demand of the segment thereby driving the market growth.
The fish vaccine market finds its application in bacterial infection, viral infection. Viral is likely to have major growth in the market of fish vaccine. This infection mainly affects and causes certain disease in fishes which is driving the growth of segment in fish vaccine market.
Based on species the fish vaccine is present for salmon, seabass, tilapia and pangasius. Salmon is projected to lead in the market.
The fish vaccine can be given by different route of administration like injection delivery system, immersion delivery system, and oral delivery system. Injection delivery system is projected to dominate in fish vaccine market. The growth is due to sterility maintenance while administrating in fish. Besides Injection delivery system can be done precisely in fish fueling the fish vaccine market growth.
The fish vaccine market has its sale through different distribution channel like veterinary pharmacies, veterinary clinics. Veterinary pharmacies is expected to lead in fish vaccine market owing to precise and proper brand vaccine sale in the market.
Geographically fish vaccine market is studied for the following region North America, Europe, Asia Pacific and RoW. North America is anticipated to dominate in the fish vaccine market thereby holding significant share of market. The increasing activity of aquaculture, fish farming in the region is propelling the demand of the market. Besides increasing awareness for vaccine and growing research and development in the region is further boosting the growth of the market. Whereas Asia Pacific is projected to witness highest growth during forecast period owing to emerging economy, increasing population consuming fish, fish products. Also, Europe is likely to have significant growth during the forecast period.
The key players in fish vaccine market are AquaTactics Fish Health, CZ Vaccines, Hipra, Ictyogroup, Lumic A/S, Marrinovak Ltd, Merck & Co. Inc. (Intervet International B.V.), Microsynbiotix, MSD Animal Health, Nisseiken Co., Ltd., Pfizer Inc (PharmaQ), Syndel USA, Tecnovax, Veterquimica SA, Virbac and Zoetis Inc. among others.
The report analyses the global fish vaccine market based on coating type, material type, application and geography. The fish vaccine is accessible in market according to different types including inactivated vaccine, attenuated vaccine, toxoid vaccine, subunit vaccine and conjugate vaccine. The fish vaccine market finds its application in bacterial infection, viral infection. Based on species the fish vaccine is present for salmon, seabass, tilapia and pangasius. The fish vaccine can be given by different route of administration like injection delivery system, immersion delivery system, and oral delivery system. The fish vaccine market has its sale through different distribution channel like veterinary pharmacies, veterinary clinics. Geographically fish vaccine market is studied for the following region North America, Europe, Asia Pacific and RoW.
The key players in fish vaccine market are AquaTactics Fish Health, CZ Vaccines, Hipra, Ictyogroup, Lumic A/S, Marrinovak Ltd, Merck & Co. Inc. (Intervet International B.V.), Microsynbiotix, MSD Animal Health, Nisseiken Co., Ltd., Pfizer Inc (PharmaQ), Syndel USA, Tecnovax, Veterquimica SA, Virbac and Zoetis Inc. among others.
Why to buy this report:
